GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hodayat Haaretz Ltd (XTAE:HDHA-M) » Definitions » Intrinsic Value: Projected FCF

Hodayat Haaretz (XTAE:HDHA-M) Intrinsic Value: Projected FCF : ₪0.00 (As of Jul. 19, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Hodayat Haaretz Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-07-19), Hodayat Haaretz's Intrinsic Value: Projected FCF is ₪0.00. The stock price of Hodayat Haaretz is ₪22.80. Therefore, Hodayat Haaretz's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Hodayat Haaretz's Intrinsic Value: Projected FCF or its related term are showing as below:

XTAE:HDHA-M's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.605
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Hodayat Haaretz Intrinsic Value: Projected FCF Historical Data

The historical data trend for Hodayat Haaretz's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hodayat Haaretz Intrinsic Value: Projected FCF Chart

Hodayat Haaretz Annual Data
Trend
Intrinsic Value: Projected FCF

Hodayat Haaretz Semi-Annual Data
Intrinsic Value: Projected FCF

Competitive Comparison of Hodayat Haaretz's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Hodayat Haaretz's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hodayat Haaretz's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hodayat Haaretz's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Hodayat Haaretz's Price-to-Projected-FCF falls into.


;
;

Hodayat Haaretz Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Hodayat Haaretz  (XTAE:HDHA-M) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Hodayat Haaretz's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=22.80/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hodayat Haaretz Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Hodayat Haaretz's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hodayat Haaretz Business Description

Traded in Other Exchanges
N/A
Address
7 Haarad Street, Tel-Aviv, ISR, 6971060
Hodayat Haaretz Ltd formerly Envizion Medical Ltd is a medical device company. It is focused on improving patient outcomes across the continuum of care, encompassing the development of advanced, personalized navigation technology for feeding tubes, responding to the challenges of the ever changing healthcare environment, while continuously focusing on the customer.

Hodayat Haaretz Headlines

No Headlines